NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy XERS

*Your capital is at risk

$5.89

-0.110 (-1.83%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 20, 2020	$4.23 -0.70%	$4.26	X	99.30%	4
iHustle84 Pro	Aug 20, 2020	$4.00 -6.10%	$4.26	X	93.90%	1
BoldBullers	Aug 20, 2020	$4.57 +7.28%	$4.26	X	92.72%	0
JS Pro	Dec 16, 2019	$8.77 +12.72%	$7.78	X	87.28%	1
JS Pro	Sep 4, 2019	$11.91 +7.30%	$11.10	X	92.70%	0
Randi.Levine.118743	Sep 4, 2019	$12.00 +8.11%	$11.10	X	91.89%	0
$Yarin.Ifrach.23991$ Yarin.Ifrach.23991	Aug 29, 2019	$15.20 +31.60%	$11.55	X	68.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT XERIS PHARMACEUTICALS INC

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by